Kate Middleton shared a personal update on her cancer recovery after finishing the National Three Peaks Challenge. She took ...

Both the Princess of Wales and King Charles have been through cancer diagnoses, with the in-laws able to support one another ...

The Princess of Wales participated in the UK’s National Three Peaks Challenge, trekking across the highest peaks of England, Scotland and Wales. She hiked in support of the Royal Marsden Cancer ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A hard-line GOP lawmaker has introduced legislation that would ...

Be careful what you wish for. This idea, often explored in fiction, lies at the center of “Obsession,” Focus Features‘ new horror film from writer/director/editor Curry Barker. The movie follows Bear ...

Their sexual orientation or gender identity forces most of them to dire states of difficulty. For many others, it is protection visas becoming almost the only true lifeline for those in need of safety ...

The Philadelphia Eagles roster the most successful player to emerge from the International Player Pathway program: left tackle Jordan Mailata. Following the seventh round of the 2026 NFL Draft, their ...

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Lizzy leads STAT’s coverage of the FDA. Her ...

Quantum computers—devices that process information using quantum mechanical effects—have long been expected to outperform classical systems on certain tasks. Over the past few decades, researchers ...

Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.